Map Chem

Mumbai, India Founded: 2012 • Age: 14 yrs
Wholesale supplier of pharmaceutical injections, tablets, and medicines in Mumbai.
Annual revenue $4.1M Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products 8 Services tracked
Competitors 7 Brand Intelligence

About Map Chem

Map Chem is a company based in Mumbai (India) founded in 2012 by Mithalal Sethia, Ankit Sethia, and Ashish Sethia. It operates as a B2B. Map Chem offers products and services including CAVIM 2.5 g, Cepofic 1.5 mg, Albuzest Protine Powder, DULAFUN 100 MG, and Etacept 25 Mg. Map Chem operates in a competitive market with competitors including AmerisourceBergen, Entero Healthcare, Keimed, Sandor Medicaids and Mahaveer Medi Sales, among others.

  • Headquarter Mumbai, India
  • Founders Mithalal Sethia, Ankit Sethia, Ashish Sethia
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Legal Name Map Chem Private Limited
  • Date of Incorporation 27 Aug, 2004
  • Jurisdiction Mumbai, Maharashtra, India
Operational Areas
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $4.14 M (USD)
    8.06
    as on Mar 31, 2023
  • Net Profit
    $39.81 K (USD)
    14.95
    as on Mar 31, 2023
  • EBITDA
    -$430.11 K (USD)
    -419.8
    as on Mar 31, 2023
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Map Chem

Map Chem offers a comprehensive portfolio of products and services, including CAVIM 2.5 g, Cepofic 1.5 mg, Albuzest Protine Powder, DULAFUN 100 MG, and Etacept 25 Mg.

Product name locked
Category locked
Primary

Injection used for medical treatment purposes.

Product name locked
Category locked
Locked

Injection for therapeutic applications.

Product name locked
Category locked
Locked

Protein powder for health support.

Product name locked
Category locked
Locked

Tablet for medical use.

Product name locked
Category locked
Locked

Injection for specific treatments.

Product name locked
Category locked
Locked

Injection for healthcare needs.

Product name locked
Category locked
Locked

Tablet for cancer-related treatments.

Product name locked
Category locked
Locked

Tablet for medical purposes.

Funding Insights of Map Chem

Premium access

Detailed funding history for Map Chem

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Map Chem

Investments
Premium access

Investment portfolio details for Map Chem

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Map Chem

Premium access

Detailed financials for Map Chem

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Map Chem Comparisons

Map Chem Primary company
Description
Wholesale supplier of pharmaceutical injections, tablets, an...
Location
Mumbai, India
Founded Year
2012
Annual Revenue
$4.14 M (USD)
Net Profit
$39.81 K (USD)
EBITDA
-$430.11 K (USD)
Employees
Not available
Premium access

Peer comparison for Map Chem

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Map Chem

Map Chem operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AmerisourceBergen, Entero Healthcare, Keimed, Sandor Medicaids and Mahaveer Medi Sales, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Pharmaceutical distribution and supply chain services are provided globally.
Locked Locked Locked
India's leading healthcare products distribution platform
Locked Locked Locked
Temperature-sensitive medicines are distributed via cold chain logistics by Keimed.
Locked Locked Locked
Provider of medical equipment, devices, and drugs distribution services
Locked Locked Locked
Serves as a distributor of a wide range of pharmaceutical drugs.
Locked Locked Locked
Distributor of pharmaceutical raw materials
Premium access

Detailed competitors of Map Chem

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Map Chem

Premium access

Complete news archive for Map Chem

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Map Chem

Map Chem was founded in 2012.

Map Chem is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.

Ashish Sethia is the current CEO of Map Chem. They have also founded this company.

Annual revenue of Map Chem is $4.14M as on Mar 31, 2023.

Map Chem Private Limited is a private limited company based in Mumbai, Maharashtra, India, specializing in wholesale distribution of pharmaceutical products. They supply items such as injections, tablets, anti-cancer medicines, and nutritional supplements to businesses. Operating as a trader and wholesaler, they focus on quality pharmaceutical distribution, including critical care and HIV aids medicines, while ensuring compliance with GST regulations.

Map Chem's top competitors include Entero Healthcare, AmerisourceBergen and Keimed.

Map Chem offers CAVIM 2.5 g, Cepofic 1.5 mg, Albuzest Protine Powder, DULAFUN 100 MG, and 4 more products and services.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available